The ‘slam dunk’ that wasn’t: Promising cholesterol drug fails to prevent heart attacks or stroke
An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a clinical trial.